发明名称 Fibrosis inhibitor
摘要 [Object] The main object of the present invention is to provide a fibrosis inhibitor.;[Solving Means] The present invention relates to a fibrosis inhibitor containing the heterocyclic derivative represented by the following general formula (1) or a pharmaceutically acceptable salt thereof as an active ingredient;; In the formula (1), R1 and R2 are the same or different and each represents an optionally substituted aryl;R3 and R4 are the same or different and each represents hydrogen atom or alkyl;R5 represents hydrogen atom, alkyl or halogen atom;Y represents N or N→O;A represents NR6, and R6 represents hydrogen atom, alkyl, etc.;D represents alkylene or alkenylene which is optionally substituted with hydroxy;E represents phenylene or a single bond;G represents O, S, etc.; andQ represents carboxy, alkoxycarbonyl, etc.
申请公布号 USRE46364(E1) 申请公布日期 2017.04.11
申请号 US201615155202 申请日期 2016.05.16
申请人 NIPPON SHINYAKU CO., LTD. 发明人 Murakami Koji;Toramoto Takuya
分类号 A61K31/4965;C07D241/02;C07D241/20 主分类号 A61K31/4965
代理机构 代理人
主权项 1. A method for treating interstitial pneumonia comprising administering a fibrosis inhibitor containing 2-{4-[N-(5,6-diphenylpyrazin-2-yl)-N-isopropylamino]butyloxy}acetic acid, 2-{4[N-(5,6-diphenylpyrazin-2-yl)-N-isopropylamino]butyloxy}-N-(methylsulfonyl)acetamide or a pharmaceutically acceptable salt thereof as an active ingredient to a patient in need of such treatment.
地址 Kyoto JP